Related Experiment Video
Updated: May 15, 2025

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
COVID-19 Vaccination and Cardiovascular Events: A Systematic Review and Bayesian Multivariate Meta-Analysis of
Raheleh Karimi1,2, Mina Norozirad3, Foad Esmaeili4
1Student Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran.
COVID-19 vaccination was linked to an increased risk of coronary artery disease (CAD), especially after the second dose of BNT162b2. However, the third vaccine dose showed a protective effect against stroke and myocardial infarction.
Area of Science:
- Cardiology
- Immunology
- Public Health
Background:
- Investigating the association between COVID-19 vaccination and cardiovascular events is crucial for public health.
- A comprehensive strategy is needed to understand potential risks and benefits.
- Cardiovascular events include myocardial infarction, stroke, arrhythmia, and coronary artery disease (CAD).
Purpose of the Study:
- To examine the association between COVID-19 vaccination and cardiovascular events.
- To apply a comprehensive strategy for understanding vaccine-related cardiovascular risks.
- To analyze data across multiple cardiovascular outcomes.
Main Methods:
- A Bayesian multivariate meta-analysis was conducted using summary data from fifteen studies.
- Eleven studies compared vaccinated and unvaccinated groups.
- Six studies specifically compared mRNA COVID-19 vaccines (Pfizer-BioNTech and Moderna).
Main Results:
- A link was found between COVID-19 vaccination and increased CAD risk (OR, 1.70), particularly after the BNT162b2 vaccine's second dose (OR, 3.44).
- No increased risk of heart attack, arrhythmia, or stroke was observed following vaccination.
- The third vaccine dose demonstrated a protective effect against stroke (OR, 0.19) and myocardial infarction (OR, 0.003).
Conclusions:
- COVID-19 vaccination is associated with an increased risk of coronary artery disease, particularly with the BNT162b2 vaccine.
- The third vaccine dose may offer protective cardiovascular benefits.
- Future vaccine technologies should consider the association with coronary artery disease risk.
More Related Videos
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Related Concept Videos
Bias in Epidemiological Studies
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Statistical Methods for Analyzing Epidemiological Data
Confounding in Epidemiological Studies
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...